Jasper Bos
InvestorGeneral Partner at Forbion
Naarden, Netherlands
Writes $100K – $5M checks · typically $1.5M
About
Jasper Bos is a General Partner at Forbion's Growth Fund. He previously served as Senior Vice President and Managing Director at M Ventures, Merck's venture arm, which he joined in 2009, where he led a team of investment professionals managing a €400 million fund across more than 50 biotech, life sciences tools, and tech companies. He holds a PhD in Pharmacy from the University of Groningen.
Invests in
BiotechHealthtech
Experience
- Braveheart BioBoard Membercurrent2025 — presentSan Francisco Bay Area
- CatalYm GmbHBoard Membercurrent2025 — present
- CellCentricBoard Membercurrent2025 — present
- Engrail TherapeuticsBoard Membercurrent2024 — presentSan Diego, California, United States
- enGeneBoard Membercurrent2023 — presentBoston, Massachusetts, United States
- ANAVEON AGBoard Membercurrent2022 — presentBasel, Switzerland
- ForbionGeneral Partnercurrent2021 — presentNaarden, North Holland, Netherlands
- ForbionForbion European Acquisition Corporation (NASDAQ: FRBN) Chief Executive Officer2021 — 2023Amsterdam Area
- M VenturesSenior Vice President & Managing Director2019 — 2021Amsterdam
- M VenturesVice President, Head of Healthcare Fund M Ventures2016 — 2019Switzerland
- Metabomed Ltd.Member of the Board of Directors2016 — 2021Yavne
- Galecto, Inc.Member of the Board of Directors2012 — 2019
- Calypso biotech SAChairman Of The Board Of Directors2013 — 2019Geneva, Geneva, Switzerland
- Prexton Therapeutics SABoard Member2012 — 2018
- Neviah GenomicsBoard Member2012 — 2016Tel Aviv, Israel
- Merck SeronoSenior Director MS Ventures2014 — 2016
- Merck SeronoDirector Merck Serono Ventures2011 — 2014
- Merck SeronoAssociate Director Merck Serono Ventures2009 — 2011
- ObsEva SABoard Member2013 — 2016Geneva, Geneva, Switzerland
- Asceneuron SABoard Member2012 — 2015Lausanne, Vaud, Switzerland
Education
- University of GroningenPhD, pharmacy2000 — 2003
- Amsterdam Institute of FinanceCorporate Finance2006
- University of GroningenMSc, Pharmacy1993 — 1997
- meander college
Skills & more
Strategy51Biotechnology49Drug Discovery16Technology Transfer15Lifesciences23Health Economics30Oncology12Clinical Trials7Molecular Biology5Drug Development52Clinical Development17R&D5
+12 more
Regulatory AffairsBiopharmaceuticalsVaccinesGCPMarket AccessNeuroscienceCompetitive IntelligenceCommercializationBiochemistryPharmaceutical IndustryMedical WritingProtein ChemistryFrom Jasper's professional profile.
Investments
Investor
EpitherapeuticsF-StarGalectoObsEvaPrexton TherapeuticsTranslate Bio
Per the firm's website.
Colleagues at Forbion
Alexander Hoffmann
General Partner at Forbion
Alice Vickers
Advisor at Forbion
Antoine Boulanger Piette
Principal at Forbion
Audrey Cacaly
Principal at Forbion
Carlo Incerti
Operating Partner at Forbion
Dirk Kersten
Managing Partner at Forbion
Dmitrij Hristodorov
General Partner at Forbion
Geert-Jan Mulder
Managing Partner at Forbion
Frequently asked questions
- Where does Jasper Bos work?
- Jasper Bos is General Partner at Forbion.
- What does Jasper Bos invest in?
- Jasper Bos invests in Biotech, Healthtech.
- What check size does Jasper Bos write?
- Jasper Bos typically writes checks of $100K – $5M.
Same school
Also attended University of Groningen135
Ragnar JongenInvestor at DN CapitalGizem CakilInvestor at OpenView Venture PartnersYtsen van der MeerPrincipal at Cottonwood Technology FundJelle Van de PutteFund Administrator at Capricorn Venture PartnersLaura LentzExecutive Assistant at Castle Island VenturesChristophe de MontillePartner at Beyond Capital Ventures
+ 129 more
Also attended Amsterdam Institute of Finance9
Nesbit WestAdvisor - Fund Compliance at Keen Venture PartnersHugo de BruinGeneral Partner at Gilde HealthcareRiemer SminkManaging Partner at FORWARD.oneHans van HouwelingenManaging Partner at Urban Impact VenturesAsher SiddiquiFund Board & IC Member at LumikaiAhmed IbrahimChief Financial Officer at RZM Investments
+ 3 more
Shared employers
Also worked at CatalYm GmbH4
Also worked at enGene4
Also worked at M Ventures31
Roel BulthuisInvestor at SynconaArturo UrriosPartner at Ysios CapitalTherese LiechtensteinPartner at 4BIO CapitalDave RosenbergInvestor at ACVC PartnersToby LovettGeneral Counsel at World FundKeno GutierrezGeneral Partner at BioGeneration Ventures
+ 25 more
Also worked at University of Groningen16
Ragnar JongenInvestor at DN CapitalXander WolfkampSenior Investment Manager at NPM Capital N.V.Ashley KlapwijkInvestment Manager at Eneco VenturesBoudewijn HulstInvestmentmanager IT NOM at NV NOMDavid VroomInvestmentmanager NOM at NV NOMJisk de VriesInvestmentmanager NOM at NV NOM
+ 10 more








































_edited_edited.jpg)





